{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T02:01:14Z","timestamp":1787968874228,"version":"build-2784847793"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,11,3]],"date-time":"2018-11-03T00:00:00Z","timestamp":1541203200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2018,11,3]],"date-time":"2018-11-03T00:00:00Z","timestamp":1541203200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["U19 MH069056"],"award-info":[{"award-number":["U19 MH069056"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["K23 MH086690"],"award-info":[{"award-number":["K23 MH086690"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"crossref","award":["U19 MH069056"],"award-info":[{"award-number":["U19 MH069056"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","award":["Study medication and Placebo, lab testing, funds for subject recruitment"],"award-info":[{"award-number":["Study medication and Placebo, lab testing, funds for subject recruitment"]}],"id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014593","name":"Neurocrine Biosciences","doi-asserted-by":"crossref","award":["pharmacokinetic analyses"],"award-info":[{"award-number":["pharmacokinetic analyses"]}],"id":[{"id":"10.13039\/100014593","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Epigenet"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13148-018-0569-x","type":"journal-article","created":{"date-parts":[[2018,11,3]],"date-time":"2018-11-03T12:53:40Z","timestamp":1541249620000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["DNA methylation levels are associated with CRF1 receptor antagonist treatment outcome in women with post-traumatic stress disorder"],"prefix":"10.1186","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9631-7093","authenticated-orcid":false,"given":"Julius C.","family":"Pape","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tania","family":"Carrillo-Roa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara O.","family":"Rothbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles B.","family":"Nemeroff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darina","family":"Czamara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony S.","family":"Zannas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Iosifescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay J.","family":"Mathew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas C.","family":"Neylan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen S.","family":"Mayberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boadie W.","family":"Dunlop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth B.","family":"Binder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,3]]},"reference":[{"issue":"7","key":"569_CR1","doi-asserted-by":"publisher","first-page":"e51","DOI":"10.1016\/j.biopsych.2017.03.007","volume":"82","author":"John H. Krystal","year":"2017","unstructured":"Krystal JH, Davis LL, Neylan TC, Raskind MA, Schnurr PP, Stein MB, et al. It is time to address the crisis in the pharmacotherapy of posttraumatic stress disorder: a consensus statement of the PTSD psychopharmacology working group. Biol Psychiatry. 2017. https:\/\/doi.org\/10.1016\/j.biopsych.2017.03.007.","journal-title":"Biological Psychiatry"},{"key":"569_CR2","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.neuropharm.2011.03.009","volume":"62","author":"D Mehta","year":"2012","unstructured":"Mehta D, Binder EB. Gene \u00d7 environment vulnerability factors for PTSD: the HPA-axis. Neuropharmacology. 2012;62:654\u201362.","journal-title":"Neuropharmacology"},{"key":"569_CR3","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1038\/mp.2009.141","volume":"15","author":"EB Binder","year":"2010","unstructured":"Binder EB, Nemeroff CB. The CRF system, stress, depression and anxiety-insights from human genetic studies. Mol Psychiatry. 2010;15:574\u201388.","journal-title":"Mol Psychiatry"},{"key":"569_CR4","first-page":"135","volume":"2","author":"G Laryea","year":"2012","unstructured":"Laryea G, Arnett MG, Muglia LJ. Behavioral studies and genetic alterations in corticotropin-releasing hormone (CRH) neurocircuitry: insights into human psychiatric disorders. Behav Sci (Basel, Switzerland). 2012;2:135\u201371.","journal-title":"Behav Sci (Basel, Switzerland)"},{"key":"569_CR5","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1176\/ajp.156.4.585","volume":"156","author":"DG Baker","year":"1999","unstructured":"Baker DG, West SA, Nicholson WE, Ekhator NN, Kasckow JW, Hill KK, et al. Serial CSF corticotropin-releasing hormone levels and adrenocortical activity in combat veterans with posttraumatic stress disorder. Am J Psychiatry. 1999;156:585\u20138.","journal-title":"Am J Psychiatry"},{"key":"569_CR6","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1176\/ajp.154.5.624","volume":"154","author":"JD Bremner","year":"1997","unstructured":"Bremner JD, Licinio J, Darnell A, Krystal JH, Owens MJ, Southwick SM, et al. Elevated CSF corticotropin-releasing factor concentrations in posttraumatic stress disorder. Am J Psychiatry. 1997;154:624\u20139.","journal-title":"Am J Psychiatry"},{"key":"569_CR7","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1016\/S0006-3223(03)00571-7","volume":"54","author":"FJ Sautter","year":"2003","unstructured":"Sautter FJ, Bissette G, Wiley J, Manguno-Mire G, Schoenbachler B, Myers L, et al. Corticotropin-releasing factor in posttraumatic stress disorder (PTSD) with secondary psychotic symptoms, nonpsychotic PTSD, and healthy control subjects. Biol Psychiatry. 2003;54:1382\u20138.","journal-title":"Biol Psychiatry"},{"key":"569_CR8","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1146\/annurev-psych-010416-044053","volume":"68","author":"T Halldorsdottir","year":"2017","unstructured":"Halldorsdottir T, Binder EB. Gene \u00d7 environment interactions: from molecular mechanisms to behavior. Annu Rev Psychol. 2017;68:215\u201341.","journal-title":"Annu Rev Psychol"},{"key":"569_CR9","doi-asserted-by":"publisher","first-page":"4099","DOI":"10.1523\/JNEUROSCI.3672-13.2014","volume":"34","author":"YG Glaser","year":"2014","unstructured":"Glaser YG, Zubieta J-K, Hsu DT, Villafuerte S, Mickey BJ, Trucco EM, et al. Indirect effect of corticotropin-releasing hormone receptor 1 gene variation on negative emotionality and alcohol use via right ventrolateral prefrontal cortex. J Neurosci. 2014;34:4099\u2013107.","journal-title":"J Neurosci"},{"key":"569_CR10","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1017\/S0954579411000599","volume":"23","author":"D Cicchetti","year":"2011","unstructured":"Cicchetti D, Rogosch FA, Oshri A. Interactive effects of corticotropin releasing hormone receptor 1, serotonin transporter linked polymorphic region, and child maltreatment on diurnal cortisol regulation and internalizing symptomatology. Dev Psychopathol. 2011;23:1125\u201338.","journal-title":"Dev Psychopathol"},{"key":"569_CR11","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3389\/neuro.08.041.2009","volume":"3","author":"C Heim","year":"2009","unstructured":"Heim C, Bradley B, Mletzko TC, Deveau TC, Musselman DL, Nemeroff CB, et al. Effect of childhood trauma on adult depression and neuroendocrine function: sex-specific moderation by CRH receptor 1 gene. Front Behav Neurosci. 2009;3:41.","journal-title":"Front Behav Neurosci"},{"key":"569_CR12","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s00213-012-2956-x","volume":"227","author":"PB Mahon","year":"2013","unstructured":"Mahon PB, Zandi PP, Potash JB, Nestadt G, Wand GS. Genetic association of FKBP5 and CRHR1 with cortisol response to acute psychosocial stress in healthy adults. Psychopharmacology. 2013;227:231\u201341.","journal-title":"Psychopharmacology"},{"key":"569_CR13","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.psyneuen.2014.02.002","volume":"43","author":"JA Sumner","year":"2014","unstructured":"Sumner JA, McLaughlin KA, Walsh K, Sheridan MA, Koenen KC. CRHR1 genotype and history of maltreatment predict cortisol reactivity to stress in adolescents. Psychoneuroendocrinology. 2014;43:71\u201380.","journal-title":"Psychoneuroendocrinology"},{"key":"569_CR14","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.biopsych.2009.05.012","volume":"66","author":"AR Tyrka","year":"2009","unstructured":"Tyrka AR, Price LH, Gelernter J, Schepker C, Anderson GM, Carpenter LL. Interaction of childhood maltreatment with the corticotropin-releasing hormone receptor gene: effects on hypothalamic-pituitary-adrenal axis reactivity. Biol Psychiatry. 2009;66:681\u20135.","journal-title":"Biol Psychiatry"},{"key":"569_CR15","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1186\/1745-6215-15-240","volume":"15","author":"BW Dunlop","year":"2014","unstructured":"Dunlop BW, Rothbaum BO, Binder EB, Duncan E, Harvey PD, Jovanovic T, et al. Evaluation of a corticotropin releasing hormone type 1 receptor antagonist in women with posttraumatic stress disorder: study protocol for a randomized controlled trial. Trials. 2014;15:240.","journal-title":"Trials"},{"key":"569_CR16","first-page":"5295","volume":"23","author":"BW Dunlop","year":"2017","unstructured":"Dunlop BW, Binder EB, Iosifescu D, Mathew SJ, Neylan TC, Pape JC, et al. Corticotropin-releasing factor type 1 receptor antagonism is ineffective for women with posttraumatic stress disorder. Biol Psychiatry. 2017;23:5295\u2013301.","journal-title":"Biol Psychiatry"},{"key":"569_CR17","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.neubiorev.2017.01.027","volume":"75","author":"PJ Colvonen","year":"2017","unstructured":"Colvonen PJ, Glassman LH, Crocker LD, Buttner MM, Orff H, Schiehser DM, et al. Pretreatment biomarkers predicting PTSD psychotherapy outcomes: a systematic review. Neurosci Biobehav Rev. 2017;75:140\u201356.","journal-title":"Neurosci Biobehav Rev"},{"key":"569_CR18","doi-asserted-by":"publisher","unstructured":"Lehrner A, Yehuda R. Biomarkers of PTSD: military applications and considerations. Eur J Psychotraumatol. 2014;5. https:\/\/doi.org\/10.3402\/ejpt.v5.23797 .","DOI":"10.3402\/ejpt.v5.23797"},{"key":"569_CR19","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.neuropharm.2014.01.013","volume":"80","author":"T Klengel","year":"2014","unstructured":"Klengel T, Pape J, Binder EB, Mehta D. The role of DNA methylation in stress-related psychiatric disorders. Neuropharmacology. 2014;80:115\u201332.","journal-title":"Neuropharmacology"},{"key":"569_CR20","doi-asserted-by":"publisher","first-page":"e368","DOI":"10.1038\/tp.2014.3","volume":"4","author":"B Labont\u00e9","year":"2014","unstructured":"Labont\u00e9 B, Azoulay N, Yerko V, Turecki G, Brunet A. Epigenetic modulation of glucocorticoid receptors in posttraumatic stress disorder. Transl Psychiatry. 2014;4:e368.","journal-title":"Transl Psychiatry"},{"key":"569_CR21","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.biopsych.2014.02.006","volume":"77","author":"R Yehuda","year":"2015","unstructured":"Yehuda R, Flory JD, Bierer LM, Henn-Haase C, Lehrner A, Desarnaud F, et al. Lower methylation of glucocorticoid receptor gene promoter 1F in peripheral blood of veterans with posttraumatic stress disorder. Biol Psychiatry. 2015;77:356\u201364.","journal-title":"Biol Psychiatry"},{"key":"569_CR22","doi-asserted-by":"publisher","first-page":"118","DOI":"10.3389\/fpsyt.2013.00118","volume":"4","author":"R Yehuda","year":"2013","unstructured":"Yehuda R, Daskalakis NP, Desarnaud F, Makotkine I, Lehrner AL, Koch E, et al. Epigenetic biomarkers as predictors and correlates of symptom improvement following psychotherapy in combat veterans with PTSD. Front Psychiatry. 2013;4:118.","journal-title":"Front Psychiatry"},{"key":"569_CR23","first-page":"219","volume":"7","author":"Z Wang","year":"2016","unstructured":"Wang Z, Young MRI. PTSD, a disorder with an immunological component. Front Immunol. 2016;7:219.","journal-title":"Front Immunol"},{"key":"569_CR24","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.jpsychores.2012.10.013","volume":"74","author":"JM Gill","year":"2013","unstructured":"Gill JM, Saligan L, Lee H, Rotolo S, Szanton S. Women in recovery from PTSD have similar inflammation and quality of life as non-traumatized controls. J Psychosom Res. 2013;74:301\u20136.","journal-title":"J Psychosom Res"},{"key":"569_CR25","first-page":"301","volume":"10","author":"AG Gocan","year":"2012","unstructured":"Gocan AG, Bachg D, Schindler AE, Rohr UD. Balancing steroidal hormone cascade in treatment-resistant veteran soldiers with PTSD using a fermented soy product (FSWW08): a pilot study. Horm Mol Biol Clin Invest. 2012;10:301\u201314.","journal-title":"Horm Mol Biol Clin Invest"},{"key":"569_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jpsychires.2014.03.016","volume":"54","author":"J Morath","year":"2014","unstructured":"Morath J, Gola H, Sommershof A, Hamuni G, Kolassa S, Catani C, et al. The effect of trauma-focused therapy on the altered T cell distribution in individuals with PTSD: evidence from a randomized controlled trial. J Psychiatr Res. 2014;54:1\u201310.","journal-title":"J Psychiatr Res"},{"key":"569_CR27","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/1471-2105-13-86","volume":"13","author":"E Houseman","year":"2012","unstructured":"Houseman E, Accomando WP, Koestler DC, Christensen BC, Marsit CJ, Nelson HH, et al. DNA methylation arrays as surrogate measures of cell mixture distribution. BMC Bioinformatics. 2012;13:86.","journal-title":"BMC Bioinformatics"},{"key":"569_CR28","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/ng0895-435","volume":"13","author":"A Kirillov","year":"1996","unstructured":"Kirillov A, Kistler B, Mostoslavsky R, Cedar H, Wirth T, Bergman Y. A role for nuclear NF-kappaB in B-cell-specific demethylation of the Igkappa locus. Nat Genet. 1996;13:435\u201341.","journal-title":"Nat Genet"},{"key":"569_CR29","doi-asserted-by":"publisher","first-page":"e1003994","DOI":"10.1371\/journal.pgen.1003994","volume":"9","author":"A Feldmann","year":"2013","unstructured":"Feldmann A, Ivanek R, Murr R, Gaidatzis D, Burger L, Sch\u00fcbeler D. Transcription factor occupancy can mediate active turnover of DNA methylation at regulatory regions. PLoS Genet. 2013;9:e1003994.","journal-title":"PLoS Genet"},{"key":"569_CR30","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1523\/JNEUROSCI.4164-06.2007","volume":"27","author":"ICG Weaver","year":"2007","unstructured":"Weaver ICG, D\u2019Alessio AC, Brown SE, Hellstrom IC, Dymov S, Sharma S, et al. The transcription factor nerve growth factor-inducible protein a mediates epigenetic programming: altering epigenetic marks by immediate-early genes. J Neurosci. 2007;27:1756\u201368.","journal-title":"J Neurosci"},{"key":"569_CR31","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1093\/emboj\/20.8.1974","volume":"20","author":"H Thomassin","year":"2001","unstructured":"Thomassin H, Flavin M, Espin\u00e1s ML, Grange T. Glucocorticoid-induced DNA demethylation and gene memory during development. EMBO J. 2001;20:1974\u201383.","journal-title":"EMBO J"},{"key":"569_CR32","doi-asserted-by":"publisher","first-page":"3028","DOI":"10.1038\/emboj.2011.210","volume":"30","author":"M Wiench","year":"2011","unstructured":"Wiench M, John S, Baek S, Johnson TA, Sung M-H, Escobar T, et al. DNA methylation status predicts cell type-specific enhancer activity. EMBO J. 2011;30:3028\u201339.","journal-title":"EMBO J"},{"key":"569_CR33","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.psyneuen.2006.12.009","volume":"32","author":"CS de Kloet","year":"2007","unstructured":"de Kloet CS, Vermetten E, Heijnen CJ, Geuze E, Lentjes EGWM, Westenberg HGM. Enhanced cortisol suppression in response to dexamethasone administration in traumatized veterans with and without posttraumatic stress disorder. Psychoneuroendocrinology. 2007;32:215\u201326.","journal-title":"Psychoneuroendocrinology"},{"key":"569_CR34","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/j.1749-6632.2009.04979.x","volume":"1179","author":"R Yehuda","year":"2009","unstructured":"Yehuda R. Status of glucocorticoid alterations in post-traumatic stress disorder. Ann N Y Acad Sci. 2009;1179:56\u201369.","journal-title":"Ann N Y Acad Sci"},{"key":"569_CR35","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.psyneuen.2007.04.001","volume":"32","author":"M Olff","year":"2007","unstructured":"Olff M, de Vries G-J, G\u00fczelcan Y, Assies J, Gersons BPR. Changes in cortisol and DHEA plasma levels after psychotherapy for PTSD. Psychoneuroendocrinology. 2007;32:619\u201326.","journal-title":"Psychoneuroendocrinology"},{"key":"569_CR36","doi-asserted-by":"publisher","first-page":"20140048","DOI":"10.1098\/rsfs.2014.0048","volume":"4","author":"R Yehuda","year":"2014","unstructured":"Yehuda R, Pratchett LC, Elmes MW, Lehrner A, Daskalakis NP, Koch E, et al. Glucocorticoid-related predictors and correlates of post-traumatic stress disorder treatment response in combat veterans. Interface Focus. 2014;4:20140048.","journal-title":"Interface Focus"},{"key":"569_CR37","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature11247","volume":"489","author":"ENCODE Project Consortium TEP","year":"2012","unstructured":"ENCODE Project Consortium TEP. An integrated encyclopedia of DNA elements in the human genome. Nature. 2012;489:57\u201374.","journal-title":"Nature"},{"key":"569_CR38","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1002\/jts.2490080106","volume":"8","author":"DD Blake","year":"1995","unstructured":"Blake DD, Weathers FW, Nagy LM, Kaloupek DG, Gusman FD, Charney DS, et al. The development of a clinician-administered PTSD scale. J Trauma Stress. 1995;8:75\u201390.","journal-title":"J Trauma Stress"},{"key":"569_CR39","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1002\/jts.2490060405","volume":"6","author":"EB Foa","year":"1993","unstructured":"Foa EB, Riggs DS, Dancu CV, Rothbaum BO. Reliability and validity of a brief instrument for assessing post-traumatic stress disorder. J Trauma Stress. 1993;6:459\u201373.","journal-title":"J Trauma Stress"},{"key":"569_CR40","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1086\/519795","volume":"81","author":"S Purcell","year":"2007","unstructured":"Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MAR, Bender D, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007;81:559\u201375.","journal-title":"Am J Hum Genet"},{"key":"569_CR41","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.ajhg.2010.11.011","volume":"88","author":"J Yang","year":"2011","unstructured":"Yang J, Lee SH, Goddard ME, Visscher PM. GCTA: a tool for genome-wide complex trait analysis. Am J Hum Genet. 2011;88:76\u201382.","journal-title":"Am J Hum Genet"},{"key":"569_CR42","doi-asserted-by":"publisher","first-page":"8302","DOI":"10.1073\/pnas.1217750110","volume":"110","author":"D Mehta","year":"2013","unstructured":"Mehta D, Klengel T, Conneely KN, Smith AK, Altmann A, Pace TW, et al. Childhood maltreatment is associated with distinct genomic and epigenetic profiles in posttraumatic stress disorder. Proc Natl Acad Sci. 2013;110:8302\u20137.","journal-title":"Proc Natl Acad Sci"},{"key":"569_CR43","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1038\/nrd3702","volume":"11","author":"G Griebel","year":"2012","unstructured":"Griebel G, Holsboer F. Neuropeptide receptor ligands as drugs for psychiatric diseases: the end of the beginning? Nat Rev Drug Discov. 2012;11:462\u201378.","journal-title":"Nat Rev Drug Discov"},{"key":"569_CR44","doi-asserted-by":"publisher","first-page":"3253","DOI":"10.1523\/JNEUROSCI.5533-11.2012","volume":"32","author":"DT Hsu","year":"2012","unstructured":"Hsu DT, Mickey BJ, Langenecker SA, Heitzeg MM, Love TM, Wang H, et al. Variation in the corticotropin-releasing hormone receptor 1 (CRHR1) gene influences fMRI signal responses during emotional stimulus processing. J Neurosci. 2012;32:3253\u201360.","journal-title":"J Neurosci"},{"key":"569_CR45","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1001\/archgenpsychiatry.2007.26","volume":"65","author":"RG Bradley","year":"2008","unstructured":"Bradley RG, Binder EB, Epstein MP, Tang Y, Nair HP, Liu W, et al. Influence of child abuse on adult depression. Arch Gen Psychiatry. 2008;65:190.","journal-title":"Arch Gen Psychiatry"},{"key":"569_CR46","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3758\/BF03193146","volume":"39","author":"F Faul","year":"2007","unstructured":"Faul F, Erdfelder E, Lang A-G, Buchner A. G*power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods. 2007;39:175\u201391.","journal-title":"Behav Res Methods"},{"key":"569_CR47","volume-title":"Statistical power analysis for the behavioral sciences","author":"J Cohen","year":"1988","unstructured":"Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. Hillsdale: Lawrence Erlbaum Associates, Publishers; 1988.","edition":"2"}],"container-title":["Clinical Epigenetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-018-0569-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13148-018-0569-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-018-0569-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,5]],"date-time":"2022-09-05T04:54:40Z","timestamp":1662353680000},"score":1,"resource":{"primary":{"URL":"https:\/\/clinicalepigeneticsjournal.biomedcentral.com\/articles\/10.1186\/s13148-018-0569-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,3]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["569"],"URL":"https:\/\/doi.org\/10.1186\/s13148-018-0569-x","relation":{},"ISSN":["1868-7075","1868-7083"],"issn-type":[{"value":"1868-7075","type":"print"},{"value":"1868-7083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,3]]},"assertion":[{"value":"23 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study is being conducted in accord with the latest version of the Declaration of Helsinki. Each site\u2019s Institutional Review Board (IRB) approved the study design, procedures, and recruitment strategies, with Emory University serving as the lead site (Emory University IRB, IRB number 00022717; Mount Sinai School of Medicine IRB, IRB number 04-0900 0001 03; Baylor College of Medicine IRB, IRB number H-30433 and the Michael E DeBakey Veterans Affairs Medical Center Research and Development Program, ID number 12G19, HBP; University of California San Francisco IRB, and the San Francisco Veterans Affairs Research and Development Committee, IRB number 12-09929). The study is registered at: NCT01018992. All participants provided written informed consent before the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Dr. Mayberg reports grants from NIMH, grants, and other from GSK, during the conduct of the study; personal fees from Abbott Labs (previously St Jude Medical Inc), outside the submitted work.Dr. Dunlop reports grants from the National Institute of Mental Health during the conduct of the study; grants from Takeda, grants from Janssen, grants from Acadia, grants from Axsome, outside the submitted work.Dr. Mathew has served as a consultant to Allergan, Alkermes, and Fortress Biotech. He has received research support from NeuroRx.Dr. Iosifescu reports grants from the National Institute of Mental Health, during the conduct of the study; personal fees from Axsome, personal fees from Alkermes, grants from Brainsway, grants from LiteCure, personal fees from Lundbeck, grants from Neosync, personal fees from Otsuka, personal fees from Sunovion, outside the submitted work.Dr. Nemeroff has received research support from the National Institutes of Health (NIH) and Stanley Medical Research Institute. For the last 3\u00a0years, he was a consultant for Xhale, Takeda, Taisho Pharmaceutical Inc., Prismic Pharmaceuticals, Bracket (Clintara), Fortress Biotech, Sunovion Pharmaceuticals Inc., Sumitomo Dainippon Pharma, Janssen Research & Development LLC, Magstim, Inc., Navitor Pharmaceuticals, Inc., TC MSO, Inc., Intra-Cellular Therapies, Inc. He is a Stockholder of Xhale, Celgene, Seattle Genetics, Abbvie, OPKO Health, Antares, BI Gen Holdings, Inc., and Corcept Therapeutics Pharmaceuticals Company. Dr. Nemeroff is a member of the scientific advisory boards of the American Foundation for Suicide Prevention (AFSP), Brain and Behavior Research Foundation (BBRF) (formerly named National Alliance for Research on Schizophrenia and Depression [NARSAD]), Xhale, Anxiety Disorder Association of America (ADAA), Skyland Trail, Bracket (Clintara), Laureate Institute for Brain Research, Inc. and on the board of directors of AFSP, Gratitude America and ADAA. Dr. Nemeroff has income sources or equity of 10.000 USD or more from American Psychiatric Publishing, Xhale, Bracket (Clintara), CME Outfitters, Takeda, Intra-Cellular Therapies, Inc., and Magstim. Dr. Nemeroff holds the following patents: Method and devices for transdermal delivery of lithium (US 6,375,990B1) and Method of assessing antidepressant drug therapy via transport inhibition of monoamine neurotransmitter by ex vivo assay (US 7,148,027B2).Dr. Binder, Dr. Rothbaum, Dr. Neylan, Dr. Pape, Dr. Carrillo-Roa, Dr. Czamara and Dr. Zannas have nothing to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"136"}}